Clinical Trial Update: HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating hepatic arterial infusion chemotherapy combined with Lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Portal Vein Thrombosis

Drugs mentioned

• LENVIMA (lenvatinib)
• PD-1 inhibitors (various) (PD-1 inhibitor)

Snippet

Sponsor: Peking University | Conditions: Hepatocellular Carcinoma, Portal Vein Thrombosis | Phase 2 | Status: COMPLETED